Overall rank by patents
#45,983
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C11B (Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes).
The verdict
According to USPTO PatentsView, CV ranks #45,983 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R45983 · US Corporation #45,983 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Current Health Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
CV Sciences · this assignee
23 score
3D Lighting… · lowest
7 score
What this shows CV's Innovation Score is 22.5/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
CV Sciences, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 60% of grants classified under C11B (Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2016. By volume, CV sits between Current Health Limited and Cxense ASA.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Current Health Limited
5 patents
Curtana Pharmaceuticals, Inc.
5 patents
Cuz-d Manufacturing, Inc.
5 patents
Cuztom Kraft PTY Ltd
5 patents
CVI Laser, LLC
5 patents
Cvilux Corporation
5 patents
CVP Systems LLC
5 patents
Cxense ASA
5 patents
CV Sciences, Inc.
5 patents
What this shows CV holds 5 patents at rank #45,696, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,696 in granted patent volume.
Other assignees with the most granted patents in CV's primary technology class.
CV's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2021 | 2 | 40.0% |
Top 7 of 7 technology areas
Overall rank by patents
#45,983
of 49,997 tracked assignees
22.5 out of 100
What to do with this data
CV Sciences, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.